Dr. Erika Hamilton spoke with CURE’s editor-in-chief, Dr. Joshua K. Sabari.
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
When I later calculated the financial impact of survivorship, the numbers were staggering: more than $1 million in lost ...
Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...
HER2CLIMB-05 trial evaluated Tukysa in combination with Herceptin and Perjeta for HER2-positive metastatic breast cancer, ...
Dave Coulier sat down for an interview with CURE to discuss his recent tongue cancer diagnosis and his treatment journey.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback